Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study

Aging Male

Volumn 19, Issue 2, 2016, Pages 134-142

  Rao, Amanda ^a   Steels, Elizabeth ^b   Inder, Warrick J ^c   Abraham, Suzanne ^a   Vitetta, Luis ^a,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b RBHF Clinical Research Centre   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d Medlab   (Australia)

Author keywords

Ageing male syndrome; androgens; sexual function; testofen; testosterone; Trigonella foenum graecum

Indexed keywords

FENUGREEK EXTRACT; PLACEBO; TESTOFEN; TESTOSTERONE; UNCLASSIFIED DRUG; PLANT EXTRACT;

ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PENIS ERECTION; PLANT SEED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL; BLOOD; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; EUNUCHISM; MIDDLE AGED; PHYTOTHERAPY; PROCEDURES; QUESTIONNAIRE; TRIGONELLA;

ADULT; AGED; DOUBLE-BLIND METHOD; EUNUCHISM; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS; SEXUAL BEHAVIOR; SURVEYS AND QUESTIONNAIRES; TESTOSTERONE; TRIGONELLA;

EID: 84955135837     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2015.1135323     Document Type: Article

References (54)

1. J.E.Morley, F.E.Kaiser, H.M.PerryIII,. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp 1997;46:410–13.
2. A.M.Matsumoto Andropause: Clinical implications of the decline in serum testosterone level with aging in men. J Gerontol a Biol Sci Med Sci 2002;57:76–99.
3. H.A.Feldman, C.Longcope, C.A.Derby,. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–98.
4. G.Sartorius, S.Spasevska, A.Idan,. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf). 2012;77:755–63.
5. E.M.1.Camacho, I.T.Huhtaniemi, T.W.O'Neill,. EMAS Group. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013 Feb 20;168:445–55.
6. Z.Shi, A.B.Araujo, S.Martin,. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab. 2013 Aug;98:3289–97.
7. D.M.Keenan, P.Y.Takahashi, P.Y.Liu,. An ensemble model of the male gonadal axis: illustrative application in aging men. Endocrinology 2006;147:2817–28.
8. R.Golan, J.M.Scovell, R.Ramasamy Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function. Aging Male. 2015;18:201–4.
9. J.Rodriguez-Tolrà, J.Torremadé Barreda, L.del Rio,. Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome. Aging Male 2013;16:184–90.
10. B.B.1.Yeap, A.B.Araujo, G.A.Wittert Do low testosterone levels contribute to ill-health during male ageing? Crit Rev Clin Lab Sci. 2012;49:168–82.
11. B.Hsu, R.G.Cumming, F.M.Blyth,. The longitudinal relationship of sexual function and androgen status in older men: the concord health and ageing in men project. J Clin Endocrinol Metab 2015;100:1350–8.
12. L.Antonio, F.C.Wu, T.W.O'Neill,. EMAS Study Group. Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. J Clin Endocrinol Metab 2015;100:1396–404.
13. B.Hsu, R.G.Cumming, L.M.Waite,. Longitudinal relationships between reproductive hormones and cognitive decline in older men: the concord health and ageing in men project. J Clin Endocrinol Metab 2015;100:2223–30.
14. M.Zitzmann Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009;5:673–81.
15. M.Behre, T.Tammela, S.Arver,. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male 2012;15:198–207.
16. K.T.Khaw, M.Dowsett, E.Folkerd,. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007;116:2694–701.
17. D.E.Laaksonen, L.Niskanen, K.Punnonen,. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036–41.
18. T.J.Cicero Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male. Fed Proc 1980;39:2551–4.
19. J.A.Elliott, S.E.Opper, S.Agarwal, E.E.Fibuch Non-analgesic effects of opioids: opioids and the endocrine system. Curr Pharm Des 2012;18:6070–8.
20. E.P.Corssmit, E.Endert, H.P.Sauerwein, J.A.Romijn Acute effects of interferon-alpha administration on testosterone concentrations in healthy men. Eur J Endocrinol 2000;143:371–4.
21. P.Singh Andropause: current concepts. Indian J Endocrinol Metab 2013;17:621–9.
22. M.I.Ullah, D.M.Riche, C.A.Koch Transdermal testosterone replacement therapy in men. Drug Design Dev Therapy 2014;8:101–12.
23. P.Y.Liu, J.Beilin, C.Meier,. Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab 2007;92:3599–603.
24. F.C.Wu, A.Tajar, J.M.Beynon,. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123–35.
25. T.Mulligan, M.F.Frick, Q.C.Zuraw,. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762–9.
26. M.Miner, D.J.Canty, R.Shabsigh Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Postgrad Med 2008;120:130–53.
27. E.S.LeBlanc, P.Y.Wang, C.G.Lee,. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab 2011;96:3855–63.
28. T.W.Auyeung, J.S.Lee, T.Kwok,. Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. Eur J Endocrinol 2011;164:811–17.
29. L.J.Gooren Androgens and male aging: current evidence of safety and efficacy. Asian J Androl 2010;12:136–51.
30. U.Srinivas-Shankar, S.A.Roberts, M.J.Connolly,. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639–50.
31. E.Steels, A.Rao, L.Vitetta Physiological aspects of male libido enhanced by standardized Trigonella foenum-graecum extract and mineral formulation. Phytotherapy Res 2011;25:1294–300.
32. S.Wankhede, V.Mohan, P.Thakurdesai Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training: a randomized controlled pilot study. J Sport and Health Sci 2015; ‘in press.’
33. K.R.Price, I.T.Johnson, G.R.Fenwick The chemistry and biological significance of saponins in foods and feedingstuffs. Crit Rev Food Sci Nutr 1987;26:27–135.
34. U.Aswar, S.L.Bodhankar, V.Mohan, P.A.Thakurdesai Effect of furostanol glycosides from Trigonella foenum-graecum on the reproductive system of male albino rats. Phytother Res 2010;24:1482–8.
35. C.Wilborn, L.Taylor, C.Poole,. Effects of a purported aromatase and 5 a-reductase inhibitor on hormone profiles in college-age man. Int J Sport Nutr Exe 2010;20:457–65.
36. I.Daig, L.A.J.Heinemann, S.Kim,. The Aging Males Symptoms (AMS) scale: review of its methodological characteristics. Health Quality Life Outcomes 2003;1:77.
37. L.R.Derogatis, N.Mellisaratos The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther 1979;5:244–81.
38. R.Sodergad, T.Backstrom, V.Shanbhag, H.Carstensen Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801–10.
39. D.J.Buysse, C.F.Reynolds, T.H.Monk,. The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric research and practice. Psychiatry Res 1989;28:193–213.
40. K.D.Stein, S.C.Martin, D.M.Hann, P.B.Jacobsen A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 1998;6:143–52.
41. C.L.Craig, A.L.Marshall, A.Sjostrom,. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95.
42. L.A.J.Heinemann, T.Zimmermann, A.Vermeulen,. A new ‘Aging Males’ symptoms’ rating scale. Aging Male 1999;2:105–14.
43. T.G.Travison, J.E.Morley, A.B.Araujo,. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006;91:2509–13.
44. J.E.Morley, H.M.Perry, IIIR.T.Kevorkian, P.Patrick Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006;53:424–9.
45. R.Clapauch, D.J.Braga, L.P.Marinheiro,. Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires. Arq Bras Endocrinol Metabol 2008;52:1439–47.
46. Y.Miwa, T.Kaneda, O.Yokoyama Correlation between the Aging Males’ Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006;3:723–6.
47. J.Kang, IIB.K.Ham, M.M.Oh,. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean J Urol 2011;52:416–20.
48. F.Zengerling, A.Schrader, M.Cronauer,. The Aging Males' Symptoms’ Scale (AMS): predictive value for lowered circulating androgens. Aging Male 2012;15:253–7.
49. L.F.DeFina, N.B.Radford, D.Leonard,. MON-0012: testosterone level in men is lower with increasing BMI and decreasing cardiorespiratory fitness but is not related to age. Endocrine Society's 96th Annual Meeting and Expo, 21–24 June 2014, Chicago.
50. I.Huhtaniemi Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 2014;16:192–202.
51. L.Correa, A.J.Rombaldi, M.C.da Silva Physical activity and aging male symptoms in a southern Brazilian population. Rev Bras Med Esporte 2011;17:228–31.
52. M.E.Beutel, J.Wiltink, E.W.Hauck,. Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 2005;47:749–55.
53. C.Pexman-Fieth, H.M.Behre, A.Morales,. A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male 2014;17:1–11.
54. B.Lunenfeld, G.Mskhalaya, M.Zitzmann,. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male 2015;18:5–15.